Видео ютуба по тегу Factor Xia Inhibitors

Factor XI/XIa Inhibitors for Stroke Prevention: Evolving Evidence and Clinical Relevance
Factor XI/XIa Inhibitors for Stroke Prevention: Evolving Evidence and Clinical Relevance
An update on studies investigating Factor XIa inhibitors for secondary stroke prevention
An update on studies investigating Factor XIa inhibitors for secondary stroke prevention
Methods of Factor XI Inhibition and Therapies in Development
Methods of Factor XI Inhibition and Therapies in Development
Factor XI/XIa Inhibition: Ensuring Safety and Efficacy
Factor XI/XIa Inhibition: Ensuring Safety and Efficacy
Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and How
Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and How
The existing evidence for Factor XIa inhibition in secondary stroke prevention: Phase II trials
The existing evidence for Factor XIa inhibition in secondary stroke prevention: Phase II trials
Factor XI Inhibitors are a Safer Option for Stroke Prevention
Factor XI Inhibitors are a Safer Option for Stroke Prevention
PACIFIC-Stroke: the first RCT comparing factor XIa inhibition versus placebo
PACIFIC-Stroke: the first RCT comparing factor XIa inhibition versus placebo
Phase 2B Trial of Efficacy and Safety of Factor XI Inhibition with MK-2060
Phase 2B Trial of Efficacy and Safety of Factor XI Inhibition with MK-2060
PACIFIC-AMI: Factor XIa inhibitor asundexian on top of DAPT after acute MI - #ESCCongress 2022
PACIFIC-AMI: Factor XIa inhibitor asundexian on top of DAPT after acute MI - #ESCCongress 2022
Stroke Management Evolution: Exploring Factor XIa Inhibition
Stroke Management Evolution: Exploring Factor XIa Inhibition
Factor XI inhibitors: what should clinicians know?
Factor XI inhibitors: what should clinicians know?
Meet the Trialist: Dr. Shoamanesh on Factor XI Inhibitors and the Future of Stroke Prevention
Meet the Trialist: Dr. Shoamanesh on Factor XI Inhibitors and the Future of Stroke Prevention
Anticoagulants 101 : heparin → factor XIa inhibitor | coff.farmco
Anticoagulants 101 : heparin → factor XIa inhibitor | coff.farmco
Nephrology Perspectives on the Promise of FXI/XIa Inhibitors for Anticoagulation
Nephrology Perspectives on the Promise of FXI/XIa Inhibitors for Anticoagulation
Emerging Solutions for Safer Anticoagulation: Why Factor XI?
Emerging Solutions for Safer Anticoagulation: Why Factor XI?
Next steps in the research of Factor XIa inhibition for secondary stroke prevention
Next steps in the research of Factor XIa inhibition for secondary stroke prevention
Neurology Updates on the Potential of FXI/XIa Inhibitors for Anticoagulation
Neurology Updates on the Potential of FXI/XIa Inhibitors for Anticoagulation
Знакомьтесь с участником клинических испытаний: доктор Майк Шарма о ингибиторах фактора XI и теку...
Знакомьтесь с участником клинических испытаний: доктор Майк Шарма о ингибиторах фактора XI и теку...
Updates in Thrombosis Management: The Emerging Role of Factor XI Inhibition
Updates in Thrombosis Management: The Emerging Role of Factor XI Inhibition